Metastases are not randomlv distributed in the bodv and. in general. their deposition is governed by two processes. Firstlv. the tissues that initially receive tumour cells are largely determined by haemodynamic factors (EWing. 1928) . Thus. cells from tumours with a systemic venous drainage amve first at the lungs and pulmonary metastases therefore predominate. Tumours with a portal venous drainage on the other hand usually progress initiallv to the liver. Subsequent spread. for example of upper rectal tumours. occurs in a step-wise fashion. After liver metastases have developed. progression commonly occurs to the lungs and only then to more circulatory distant sites (Thompson & Rodgers. 1952 : Viadana et al.. 1979 . Organs with a dual venous drainage spread in a fairlv predictable manner. Upper rectal and lower oesophageal tumours metastasise initially to the liver. while lower rectal and upper oesophageal tumours progress to the lungs (Weiss et al.. 1981) . The clinical situation is mirrored by many experimental systems in which cells delivered intravenously first encounter the pulmonary capillary bed and give rise to lung metastases. while intraportally administered cells seed to the liver (Procter. 1976; Murphy et al.. 1986) . Secondly. there is clearly an interaction between tumour cells and host tissues (Paget. 1889) . Clinical experience (Murphv et al.. 1986 ) and experimental data (Proctor. 1976 : Murphy et al.. 1988 indicate that tissues such as adrenal and lung are 'fertile' soils for metastatic tumour growth. while others such as colon and. in the experimental setting. liver, are relatively refractorv.
Many theories have been advanced to explain why tissues differ in their ability to sustain tumour growth. These include differences in immunological characteristics (Hanna & Fidler. 1983) , the ability to support neovascularisation and the growth factor milieu (Alexander et al.. 1985) . A further possibility is that tumour growth may be modulated by the ability of tissues to generate fibrin. Fibrin is deposited within minutes of tumour cell inoculation (Dvorak et al., 1979) and is an important component of the stroma of solid tumours (Dvorak. 1986) . Peri-tumour fibrin may be important in protecting the tumour from host defence mechanisms and in the (Donati & Semeraro. 1984 : Donati et al.. 1986 : Zacharski. 1986 ). We have previously shown that the procoagulant activity of normal tissue. as well as some malignant tumours. is due to a complex of tissue factor (TF) and activated factor VII (Francis et al.. 1988 ). This procoagulant is a potent activrator of blood coagulation factor X and appears to correlate with metastatic capacity in several situations (Carty et al., 1991) . Since factor VII is a vitamin K-dependent clotting factor, the present work was performed to explore the possibility that (1) Warfarin reduces the tissue activity of the TF-FVII complex and (2) that this is accompanied by reduced 'fertility' for experimental metastases. (Tennant. 1964 ) and the cell suspensions adjusted to 2.5 x 106 viable cells per ml. Nought point two ml of this suspension was injected via the tail vein to each of three groups of Hooded Lister rats:
Materials and methods

Sample
(1) Normal controls (n = 17).
(2) Rats maintained on Warfarin as detailed above (n = 15) starting 7 days before the experiment.
(3) Warfariised rats given 15 units of factor VII at the time of, and 4 h after, tumour cell injection (n = 13). Following tumour cell injection, Warfarinisation was maintained for 7 days. The animals were sacrificed under ether anaesthesia 16 days after injection. Pulmonary deposits. which were not otherwise obvious. were visualised according to Wexler (1966) . The trachea was cannulated and the lungs insufflated with approximately 7 ml of 15% India Blue, until they were fully stained. The lungs were then dissected, en block, from the thoracic cage and placed in a beaker of water for 5 min to remove excess ink. Finally, the organs were then placed in Fekete's solution (100 ml 70% alcohol, 1O ml 40% formaldehyde and S ml glacial acetic acid) for 24 h. Tumours, which appeared as pale areas within the black-stained normal lung tissue. were then counted by two observers unaware of the origin of the samples. and the average number for each rat recorded.
Effect of U arfarin on primary tumour grow th Animals were anticoagulated with Warfarin (Thrombotest 2-3 times control levels) as detailed above. Frozen fragments of MC28 tumours were disaggregated and 0.5 ml cell suspension (4.0 x 10' cells ml-') was injected subcutaneously into one hind leg of control (n = 3) and Warfarinised (n = 4) rats. At days 5. 7 and 12 after injection tumour size was estimated from the measurement of tumour diameter with a Vernier caliper (Hilgard et al.. 1977) . The length and width (mm) of the tumours were measured and the weight expressed in milligrams according to the formula: weight = length x width 2'.
At the end of the experiment (12 days) the animals were killed, the tumours carefully excised and wet weights determined directly. Figure 1 . bSignificantly less than the normal controls (P <0.001). 'Significantly greater than warfanrn group (P <0.02). (El-Baruni. 1990 ) and there were no macroscopic differences in the amount of George, 1987) . Interestingly, coagulation factor supplementation later than 12 h after introduction of the tumour cells had no effect on lung seeding. These data suggested that Warfarin exerts its antitumour effect via plasma anticoagulation. and is a relatively early event, possibly involving intravascular microthrombus formation and endothelial adhesion. As noted above, the degree of anticoagulation (as measured by a global test) did not seem to be related to the anti-tumour effect in the present study. Nevertheless, our data do support the concept of an early event since factor VII has a plasma half life of only 4 h. Thus, the effect of supplementation as performed in this study would not be expected to persist for more than 12 h after the injection.
Further studies with the Mtlnm model showed that the complex of coagulation factors II. IX and X enhanced lung seeding while factor VII alone had no effect (McCulloch & George, 1988) . Since defibnrnation had no effect on seeding. the authors concluded that the tumourigenic effect of the clotting factor complex was mediated by a mechanism other than fibrin formation. However, defibrination was not complete and it is difficult to exclude the possibility that sufficient fibrin-forming activity remained, especially as clotting processes on cell surfaces tend to concentrate the proteins involved. The present data appear to be at variance with the latter study, although it is difficult to directly compare that work with the present investigation. Although the factor VII preparations used were similar in both studies, the tumour models used were different and we did not assess the effect on pulmonary seeding of giving factor VII to control (i.e. nonanticoagulated) animals. However. we have shown that when blood and tissue levels of this factor are already normal, the administration of additional factor VII does not necessarily increase the total procoagulant activity, at least in lung tissue. If tissue procoagulant activity is indeed directly related to metastatic fertility this might explain why McCulloch and George (1988) found that administration of factor VII did not increase the number of lung deposits. This does not, however. explain why the complex of factors II, IX and X enhanced pulmonary seeding (Purushotham et al.. 1991) .
In an injected tumour model such as that used in the present study. the malignant cells will initially lodge in the lungs. This does not necessarily mean that the cells will form lung colonies. however, as the arrest may be transient (Fisher & Fisher, 1967) . Patterns of tumour spread may be dependent on the intrinsic properties of the tissue or tumour cells as well as anatomical factors (Fisher & Fisher. 1967 Purushotham et al. (1991) showed that the trapping of Mtln. cells in animals given clotting factor concentrates only became significantly higher than controls 60 min after injection: an effect which persisted for 12 h. The effect of Warfarin on cell trapping was not addressed in the latter study.
Separation of tissue and intravascular events is difficult using an intravenous model of tumour seeding. However. Warfanrn also impaired the growth of subcutaneously implanted MC28 fibrosarcoma cells: an experimental model that is not directly influenced by events in the vascular compartment. Reduction of primary growth of the Lewis lung carcinoma has also been reported but the mechanism of this effect was not elucidated (Hilgard et al.. 1977 ). Although we have not yet tested the effect of factor VII on primary tumour growth in control and anticoagulated animals, these results lend support to our suggestion that tissue factors may also play a role in the anti-tumour effects of oral anticoagulants.
In summary. we have shown that tissue procoagulant activity and pulmonary seeding are reduced by Warfarin and restored by factor VII. and that Warfarin has no effect on tumour cell adhesion in vitro or on short term trapping in the lung. Furthermore. the effect on lung seeding appeared to be independent of plasma coagulability and. in any case. Warfarmn also retarded primary tumour growth where intravascular events are not a confounding issue. We have recently suggested that the tissue factor-factor VII procoagulant activity of a particular normal tissue broadly correlates with the fertility of that tissue for metastasis (Carty et al.. 1991) . Given the evidence that peri-tumour fibrin deposition is an early and important event in tumour stroma formation. and that tissue procoagulant activity correlates with MC28 tumour growth. we suggest another possible explanation for the antimetastatic effects of oral anticoagulants. Namely. that the reduced tissue procoagulant activity produced by these agents reduces the abilitv of host tissues to assist in the formation of peri-tumour fibrin. This does not exclude the possibility that early plasma events related to coagulation factors. such as microthrombus formation. are also important in the development of metastases. However. the precise role of the individual vitamin K-dependent coagulation factors in the metastatic process can only be elucidated with carefully controlled experiments with purified proteins. preferablv in several different animal models.
